購読する
モデル製品
カスタムサービス
創薬研究
コミュ二ティー
hVSIG4-3xFLAG Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
hVSIG4-3xFLAG Mouse
製品名
hVSIG4-3xFLAG Mouse
製品ID
C002145
系統名
C57BL/6Cya-Vsig4em1(hVSIG4-3xFLAG tag)/Cya
背景情報
C57BL/6Cya
状況
このマウス系統を論文で使用する場合は、「hVSIG4-3xFLAG Mouse(カタログ番号C002145)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
基本情報
関連リソース
基本情報
遺伝子名
遺伝子別名
CRIg, Z39IG
NCBI ID
染色体
Chr X
MGI ID
さらに
系統詳細
VSIG4 encodes the V-set immunoglobulin domain-containing protein 4 (also known as CRIg), a type I transmembrane glycoprotein belonging to the B7 family-related immunoregulatory molecules, and serves as the receptor for complement fragments C3b and iC3b. This protein is primarily expressed on tissue-resident macrophages, with high expression on hepatic Kupffer cells, and is also found on splenic, lymph node, and peritoneal macrophages [1]. The extracellular IgV domain of VSIG4 binds C3b/iC3b, acting both as a phagocytic receptor that mediates the uptake of complement-opsonized pathogens and as an inhibitor of alternative pathway C3 and C5 convertase activity, thereby limiting excessive amplification of the complement cascade [1-2]. Recent studies have shown that VSIG4 transmits negative signals by binding to CD5 on the surface of T cells, suppressing T cell proliferation and effector functions [3]. Impaired VSIG4-mediated clearance is associated with susceptibility to bloodstream infections, and its extracellular domain can also directly bind Gram-positive bacteria [4]. In the tumor microenvironment, VSIG4 is highly expressed on Kupffer cells and tumor-associated macrophages, promoting immune evasion by suppressing tumor-specific CD8⁺ T cell responses, and is associated with poor prognosis in various solid tumors [3,5]. VSIG4 possesses dual attributes as both a complement regulator and an immune checkpoint. Anti-VSIG4 antibodies can repolarize tumor-associated macrophages and restore antitumor immunity [6].
The hVSIG4-3xFLAG mouse is a VSIG4 humanized model constructed via gene editing technology, in which the sequences from ATG start codon to partial intron 1 of mouse Vsig4 were replaced with "Kozak-Human VSIG4 CDS-3xFLAG tag-3' UTR of Mouse Vsig4-WPRE-BGH pA" cassette. This model can be used for studying the mechanisms of VSIG4 in infection clearance, complement regulation, and tumor immunity, as well as for screening, development, and preclinical in vivo evaluation of VSIG4-targeted therapies.
参考文献
Helmy KY, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell. 2006;124(5):915-927.
Wiesmann C, et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature. 2006;444(7116):217-220.
Zhou X, et al. Kupffer cell calibration of T cell responses via VSIG4-CD5 interaction promotes tumor evasion. Nat Immunol. 2026;27(6):1253-1267.
Zeng Z, et al. CRIg Functions as a Macrophage Pattern Recognition Receptor to Directly Bind and Capture Blood-Borne Gram-Positive Bacteria. Cell Host Microbe. 2016;20(1):99-106.
Jung K, et al. VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity. Biochem Biophys Res Commun. 2022;628:18-24.
Sazinsky S, et al. Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types. Int J Mol Sci. 2024;25(11).
系統作製戦略
The sequences from ATG start codon to partial intron 1 of mouse Vsig4 were replaced with "Kozak-Human VSIG4 CDS-3xFLAG tag-3' UTR of Mouse Vsig4-WPRE-BGH pA" cassette.

Figure 1. Gene editing strategy of hVSIG4-3xFLAG mice.
適用分野
VSIG4 in Infection Clearance, Complement Regulation, and Tumor Immunity: Mechanisms of Action;
Screening, Development, and Preclinical In Vivo Evaluation of VSIG4-Targeted Therapies.
関連リソース
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
